Difelikefalin Improves Itch Intensity in Notalgia Paresthetica
THURSDAY, Feb. 9, 2023 -- Oral treatment with difelikefalin results in greater reductions in itch intensity scores than placebo among patients with notalgia paresthetica, but it does not improve secondary outcomes, according to a study published in...
Read more »